Urologix Inc (ULGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,733 | -2,403 | -1,420 | -708 | -2,169 |
| Depreciation Amortization | 565 | 443 | 309 | 162 | 793 |
| Accounts receivable | 66 | 71 | -186 | -85 | 80 |
| Accounts payable and accrued liabilities | 307 | 214 | 292 | 173 | -28 |
| Other Working Capital | 463 | 5 | -286 | -526 | -368 |
| Other Operating Activity | -38 | -30 | 68 | -4 | 437 |
| Operating Cash Flow | $-2,370 | $-1,700 | $-1,223 | $-988 | $-1,255 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -272 | -213 | -190 | -13 | -81 |
| Purchase Sale Intangibles | N/A | -3 | -1 | N/A | N/A |
| Other Investing Activity | -3 | -3 | -1 | 0 | -4 |
| Investing Cash Flow | $-275 | $-216 | $-191 | $-13 | $-85 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4 | 4 | N/A | N/A | 10 |
| Financing Cash Flow | $4 | $4 | $N/A | $N/A | $10 |
| Beginning Cash Position | 5,702 | 5,702 | 5,702 | 5,702 | 7,032 |
| End Cash Position | 3,061 | 3,790 | 4,288 | 4,701 | 5,702 |
| Net Cash Flow | $-2,641 | $-1,912 | $-1,414 | $-1,001 | $-1,330 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,370 | -1,700 | -1,223 | -988 | -1,255 |
| Capital Expenditure | -272 | -213 | -190 | -13 | -81 |
| Free Cash Flow | -2,642 | -1,913 | -1,413 | -1,001 | -1,336 |